Indeglitazar

DB07724ExperimentalSmall molecule

Indeglitazar: Overview.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptors, and Peroxisome proliferator-activated receptor gamma
Curator reviewed
Formula / weight: C₁₉H₁₉NO₆S · 389.422 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyYMPALHOKRBVHOJ-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12

Targets

What you can answer from here — as of June 15, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Indeglitazar, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.